Inflammation in Human Disease: Anticytokine Therapy

Biology of Blood and Marrow Transplantation

Volumn 15, Issue 1 SUPPL., 2009, Pages 134-136

  Dinarello, Charles A ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Auto inflammatory; Caspase 1; IL 1beta

Indexed keywords

ACETYLSALICYLIC ACID; CYCLOOXYGENASE 2 INHIBITOR; CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 22; INTERLEUKIN 4; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; AUTOIMMUNE DISEASE; CROHN DISEASE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE SEVERITY; HUMAN; HYPOTENSION; IMMUNE RESPONSE; INFLAMMATION; NONHUMAN; PSORIASIS; RHEUMATOID ARTHRITIS; SEPSIS; DRUG ANTAGONISM; DRUG DELIVERY SYSTEM; METHODOLOGY; REVIEW;

CYTOKINES; DRUG DELIVERY SYSTEMS; HUMANS; INFLAMMATION;

EID: 64749100330     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2008.11.006     Document Type: Article

References (13)

1. Kosiewicz M.M., Nast C.C., Krishnan A., et al. Th1-type responses mediate spontaneous ileitis in a novel murine model of Crohn's disease. J Clin Invest 107 (2001) 695-702
2. Werman A., Werman-Venkert R., White R., et al. The precursor form of IL-1a is an intracrine proinflammatory activator of transcription. Proc Natl Acad Sci U S A 101 (2004) 2434-2439
3. Wang H., Bloom O., Zhang M., et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science 285 (1999) 248-251
4. Carriere V., Roussel L., Ortega N., et al. IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo. Proc Natl Acad Sci U S A 104 (2007) 282-287
5. Smith J.W., Longo D., Alford W.G., et al. The effects of treatment with interleukin-1a on platelet recovery after high-dose carboplatin. N Engl J Med 328 (1993) 756-761
6. Kaplanski G., Farnarier C., Kaplanski S., et al. Interleukin-1 induces interleukin-8 from endothelial cells by a juxacrine mechanism. Blood 84 (1994) 4242-4248
7. Apte R.N., Douvdevani A., Zoller M., et al. Cytokine-induced tumorogenicity: endogenous interleukin-1a expressed by fibrosarcoma cells confers reduced tumorogenicity. Immunol Lett 39 (1993) 45-52
8. Engelmann H., Novick D., and Wallach D. Two tumor necrosis factor-binding proteins purified from human urine: evidence for immunological cross-reactivity with cell surface tumor necrosis factor receptors. J Biol Chem 265 (1990) 1531-1536
9. Girardin E., Roux-Lombard P., Grau G.E., et al. Imbalance between tumor necrosis factor a and soluble TNF receptor concentrations in severe meningococcemia. Immunology 76 (1992) 20-23
10. Colotta F., Dower S.K., Sims J.E., et al. The type II "decoy" receptor: a novel regulatory pathway for interleukin-1. Immunol Today 15 (1994) 562-566
11. Horai R., Saijo S., Tanioka H., et al. Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice. J Exp Med 191 (2000) 313-320
12. Netea M.G., Puren A.J., and Dinarello C.A. A short course of oral aspirin increases IL-18-induced interferon-gamma production in whole blood cultures. Eur Cytokine Netw 11 (2000) 379-382
13. Endres S., Ghorbani R., Kelley V.E., et al. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med 320 (1989) 265-271